Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Review topic

No spam. Unsubscribe anytime.

House passes SCR102 to create post‑pandemic review of Idaho’s COVID response

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The House approved Senate Concurrent Resolution 102 on Feb. 10, 2025, authorizing a post‑event review of Idaho’s pandemic response; sponsor said the review would be limited in cost and framed as constructive analysis rather than a political inquiry.

Representative (District 8) presented Senate Concurrent Resolution 102, describing it as a post‑event review of Idaho’s handling of the COVID‑19 pandemic aimed at documenting actions and recommending improvements. The sponsor said the review was intended to be constructive and not a "witch hunt," describing past emergency actions and the value of reviewing them to improve future responses.

Representative (District 11) asked why the federal CARES Act funds were not included in the resolution’s scope or specifically referenced. Representative (District 8) said the sponsor (Senator Dan Foreman, author in the Senate) indicated the review would use a small amount — "about $10,000 or less from the general fund" — and the sponsor on the floor did not explain why CARES Act funds were omitted.

The House voted by roll call because the resolution could expend funds. The clerk recorded 54 ayes, 12 nays and 4 abstentions. The presiding officer declared Senate Concurrent Resolution 102 passed and ordered the title approved and the concurrent resolution returned to the Senate.

The resolution, as described in floor remarks, would establish a legislative review of statewide COVID actions and is intended to produce recommendations for future emergencies; the transcript records the sponsor’s emphasis on constructive analysis and a modest general‑fund cost estimate.